Tafas v. Dudas

530 F. Supp. 2d 786, 86 U.S.P.Q. 2d (BNA) 1562, 2008 U.S. Dist. LEXIS 1692, 2008 WL 112043
CourtDistrict Court, E.D. Virginia
DecidedJanuary 9, 2008
Docket1:07cv846 (JCC), 1:07cv1008 (JCC)
StatusPublished
Cited by43 cases

This text of 530 F. Supp. 2d 786 (Tafas v. Dudas) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Tafas v. Dudas, 530 F. Supp. 2d 786, 86 U.S.P.Q. 2d (BNA) 1562, 2008 U.S. Dist. LEXIS 1692, 2008 WL 112043 (E.D. Va. 2008).

Opinion

MEMORANDUM OPINION

JAMES C. CACHERIS, District Judge.

This matter is before the Court on Plaintiff Triantafyllos Tafas’s Objection to Magistrate Jones’s Opinion and Order Denying Tafas’s Motion to Compel and Quashing Tafas’s Notices of Depositions for Senior USPTO Officials. 1 For the reasons stated below, the Court will deny Tafas’s Objection.

I. Background

On January 3, 2006, Defendant United States Patent & Trademark Office (the “USPTO”) proposed a series of changes to the rules governing the procedure by which patent applications would be submitted to, and considered by, the USPTO. After a four month public comment period where the USPTO received more than five hundred (500) written comments, the USP-TO published its Final Rules on August 21, 2007. These Final Rules were originally set to take effect on November 1, 2007. Plaintiff Triantafyllos Tafas (“Tafas”) filed *791 a Complaint in this Court on August 22, 2007, which he then amended on September 7, 2007. On October 5, 2007, the USP-TO filed with this Court the nearly 10,000-page administrative record, which included the 127-page Federal Register notice that set out the Final Rules and explained their rationale.

On October 9, 2007, Plaintiff SmithKline Beecham Corporation (“GSK”) filed its own Complaint against the USPTO, and that case was consolidated with Tafas’s case on October 17, 2007. After extensive briefing and argument, on October 31, 2007, this Court granted GSK’s motion for a preliminary injunction preventing the Final Rules from taking effect. Prior to the entry of the preliminary injunction, Tafas and the USPTO had agreed on a briefing schedule, which this Court approved in a Consent Order dated September 21, 2007. On October 22, 2007, this Court then approved an Amended Consent Order, which recognized the possibility of litigation over the adequacy or completeness of the record but did not mention a discovery period.

On November 5, 2007, Tafas noticed the depositions of four (4) USPTO officials who Tafas believed were significantly involved in the promulgation of the Final Rules: Defendant Undersecretary of Commerce Jon W. Dudas, Commissioner of Patents Jon J. Doll, Deputy Commissioner for Patent Examination John L. Love, and USPTO Senior Patent Attorney Robert Bahr. On November 9, 2007, the USPTO filed a Motion for Issuance of a Proposed Briefing Schedule in Lieu of a Standard Initial Scheduling Order in which it demanded that summary judgment briefs be filed no later than December 20, 2007. The USPTO also asked the Court to quash Tafas’s notices of deposition and to enter an order barring all discovery in this case. In response, Tafas argued that the USP-TO had engaged in a biased and results-oriented rulemaking process, acted in bad faith, and withheld factual information and documents from the administrative record such that discovery concerning the USP-TO’s inconsistent positions and incomplete administrative record was warranted. Ta-fas further contended that discovery was permissible concerning his bad faith certification claim under the Regulatory Flexibility Act (“RFA”) as well as on his constitutional claims.

On November 16, 2007, Magistrate Judge Jones held a hearing on the USP-TO’s Motion. At that hearing, Tafas argued that the USPTO had provided an incomplete administrative record and that it was improperly refusing to provide a privilege log. Magistrate Judge Jones took the matter under advisement and asked the parties to submit additional memoranda concerning the privilege issue and whether discovery should be permitted with respect to Tafas’s constitutional claims. Subsequently, GSK filed a Motion for an order requiring the USPTO to submit a privilege log and a Motion to Compel a complete administrative record. Tafas, in addition to filing two supplemental memoranda, also filed a Motion to Compel on November 20, 2007, requesting that the USPTO produce all materials that were required to be placed in the administrative record and to substantiate any excisions from the record based on claims of privilege.

Magistrate Judge Jones then held another hearing on November 27, 2007. In an oral ruling from the bench, the Magistrate Judge granted the USPTO’s Motion for a protective order and denied Tafas’s Motion to Compel and GSK’s two Motions. This oral ruling was supplemented by a written Order on November 28, 2007, in which Magistrate Judge Jones wrote that Tafas and GSK were seeking discovery in order to “go on a classic ‘fishing expedi *792 tion.’ ” Magistrate Judge Jones’s Mem. Op. and Order at 2. The following day, the Magistrate Judge issued an Order setting the schedule for the parties’ submission of motions for summary judgment.

On December 7, 2007, Tafas filed his Objection to Magistrate Jones’s Opinion and Order Denying Tafas’s Motion to Compel and Quashing Tafas’s Notices of Depositions for Senior USPTO Officials. This matter is currently before the Court.

II. Standard of Review

Rule 72(a) of the Federal Rules of Civil Procedure permits a party to submit objections to a magistrate judge’s ruling on non-dispositive matters, such as discovery orders. Fed.R.Civ.P. 72(a); 28 U.S.C. § 636(b)(1)(A); see Federal Election Comm’n v. The Christian Coalition, 178 F.R.D. 456, 459-60 (E.D.Va.1998)(citing Thomas E. Hoar, Inc. v. Sara Lee Corp., 900 F.2d 522, 525 (2d Cir.1990)). As a non-dispositive matter, the review of a magistrate’s discovery order is properly governed by the “clearly erroneous or contrary to law” standard of review. See Jesselson v. Outlet Assocs. of Williamsburg, Ltd. Partnership, 784 F.Supp. 1223, 1228 (E.D.Va.1991).

Only if a magistrate judge’s decision is “clearly erroneous or contrary to law” may a district court judge modify or set aside any portion of the decision. Fed.R.Civ.P. 72(a); see 28 U.S.C. § 636(b)(1)(A). A court’s “finding is ‘clearly erroneous’ when although there is evidence to support it, the reviewing court on the entire evidence is left with the definite and firm conviction that a mistake has been committed.” United States v. United States Gypsum Co., 333 U.S. 364, 395, 68 S.Ct. 525, 92 L.Ed. 746 (1948); see also Harman v. Levin, 772 F.2d 1150, 1152 (4th Cir.1985). A treatise on federal practice and procedure describes altering a magistrate’s non-dispositive orders as “extremely difficult to justify.” 12 Charles A. Wright, Arthur R. Miller & Richard L. Marcus, Federal Practice and Procedure § 3069 (2d ed.1997).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
530 F. Supp. 2d 786, 86 U.S.P.Q. 2d (BNA) 1562, 2008 U.S. Dist. LEXIS 1692, 2008 WL 112043, Counsel Stack Legal Research, https://law.counselstack.com/opinion/tafas-v-dudas-vaed-2008.